Howard Davis is the founder of Akamis Bio. Akamis Bio has raised $90M in total funding. Latest round: Series A. Based in Cambridge, MA.
Howard E. Davis, Ph.D. is the Chief Executive Officer of Akamis Bio, a clinical-stage oncology company. He joined Akamis Bio in July 2022 following its rebranding from PsiOxus Therapeutics and the announcement of a $30 million convertible note financing.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide